Syneos Health (United States)

Recent papers from Syneos Health (United States)

1. Factors associated with rates of long-acting injectable antipsychotic use for schizophrenia: A subgroup analysis of the multinational ADVANCE studyPsychiatry Research · 2026
2. The Waiting Game: How NGS and Guideline-Concordant-Care Timing Shape Survival in Advanced NSCLCCancers · 2026
3. Complete genome sequence of Bifidobacterium longum subsp. longum strain iVE-15Microbiology Resource Announcements · 2026
4. P37 Drug reaction with eosinophilia and systemic symptoms eosinophil transcriptomes show distinct interleukin (IL)-5 and IL-3 regulation as compared with atopic dermatitis and asthmaBritish Journal of Dermatology · 2026
5. A Phase 1, Open‐Label, Randomized Study to Investigate the Pharmacokinetics and Safety of Multiple Doses of Intranasal Naloxone in Healthy ParticipantsClinical and Translational Science · 2026
6. Opportunities and Challenges for Surveillance of Congenital Anomalies in Sub‐Saharan AfricaBirth Defects Research · 2026
7. 18 th GCC Closed Forum: Compliance with FDA Biomarkers Guidance, Novel ELN/LIMS Platforms, Sample Reconciliation, Emerging Technologies, Improvements in ELISpot, Post-extraction Sample Stability, LBA Singlicate, Regulatory Inspections, Chicken anti-Human IgG, Cross-validation HarmonizationBioanalysis · 2026
8. Evaluating the relationship between the 4-item migraine interictal burden scale and other patient-reported outcome measures: a post hoc analysis from a phase 3 migraine prevention studyFrontiers in Neurology · 2026
9. Genome assembly and annotation of Rugonectria rugulosa , a fungus associated with avocado ( Persea americana cv. Hass) trunk canker in ColombiaMicrobiology Resource Announcements · 2026
10. Comprehensive Long-Term Changes in Cardiovascular Risk Biomarkers With TirzepatideJournal of the American College of Cardiology · 2026
11. Role of transcript-based HER2 quantification in classification and determining therapeutic eligibility.Journal of Clinical Oncology · 2026
12. Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or ObesityJAMA Dermatology · 2026
13. Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative ColitisUnited European Gastroenterology Journal · 2026
14. Impact of Healthcare Professional Role and Care Setting on Attitudes Toward Long-Acting Injectable Antipsychotics for Schizophrenia: A Subgroup Analysis of the Multinational ADVANCE StudySchizophrenia Bulletin Open · 2026
15. Intubation in children presenting with seizures to a pediatric emergency department in a safety net hospitalFrontiers in Pediatrics · 2026
16. Evaluation of Guideline-Recommended Care in First-Line Treatment for Advanced/Metastatic Non-Small Cell Lung Cancer Patients who underwent Next-Generation Sequencing Testing: Results from a Real-World StudyCancer Treatment and Research Communications · 2026
17. Clinical Efficacy with Evolocumab among Japanese Patients in PROFICIO: A Pooled Analysis of 1,040 PatientsJournal of Atherosclerosis and Thrombosis · 2026
18. Ethics review of digital health research: Rethinking rights of participantsPerspectives in Clinical Research · 2026
19. Method qualification of an electrochemiluminescence assay to quantitate anti-FcεR1α autoantibodies: a case study of an antibody-based biomarkerBioanalysis · 2026
20. Cost-effectiveness of vaccination of older adults with an MF59®-adjuvanted quadrivalent influenza vaccine compared to standard-dose and high-dose vaccines in South Korea and TaiwanVaccine · 2026